BG

Beena Gautam

Active Director Director DIN 05273018
DIN 05273018 First appointment May 2012 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2012
Shareholding value •••• Premium profile

About Beena Gautam

Data last updated:

Beena Gautam is a Director at Glynvet Pharma Private Limited (since 2012). The company operates in Trading. Glynvet Pharma Private Limited reported revenue of ₹12.8 Lakh (FY 2025).

DIN 05273018
Primary Designation Director
Industry Trading
First Appointment 14 May 2012
Oldest Company Age 14 yrs
Largest company Glynvet Pharma Private Limited · ₹12.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Glynvet Pharma Private Limited U24233UP2012PTC050465
Director14 May 20122012₹12.8 Lakh (FY 2025)Active

Board colleagues of Beena Gautam

NameDINCompanyDesignation
Vivek Kumar Gautam05273019Glynvet Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Glynvet Pharma Private Limited
Premium access

Shareholding and investment profile for Beena Gautam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Beena Gautam

Beena Gautam currently holds 1 directorship: Glynvet Pharma Private Limited (Director, since 14 May 2012, revenue ₹12.8 Lakh (FY 2025)).

Beena Gautam was first appointed on 14 May 2012 as Director at Glynvet Pharma Private Limited.

The current boards of Beena Gautam's companies include Vivek Kumar Gautam (Glynvet Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available